Clinical outcomes and risk factor of immune checkpoint inhibitors-related pneumonitis in non-small cell lung cancer patients with chronic obstructive pulmonary disease

OBJECTIVES: Chronic obstructive pulmonary disease (COPD) is the most common co-morbidity associated with non-small cell lung cancer (NSCLC) patients. Immune checkpoint inhibitors related pneumonitis (CIP) is a common immune-related adverse event that can be life-threatening. The study aims to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Zhu, Qu, Jingjing, Yao, Yake, Xu, Fei, Lu, Shan, Zhang, Pei, Yao, Yinan, Li, Ning, Zhou, Jianying, Wang, Yuehong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716670/
https://www.ncbi.nlm.nih.gov/pubmed/36456932
http://dx.doi.org/10.1186/s12890-022-02190-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716670/
https://www.ncbi.nlm.nih.gov/pubmed/36456932
http://dx.doi.org/10.1186/s12890-022-02190-w

Ejemplares similares